A Study of the Immune Response to Heplisav in Healthy Older Adults

Summary

This study will investigate the response of the immune system to a hepatitis B (HB) vaccine in healthy adults 50 to 70 years of age. This study is partially funded by the National Institute of Allergy and Infectious Diseases.

Timeline

Start

2013-11

Primary completion

2015-02

Completion

2015-03

Drugs

Indications